Skip to main content
. 2018 Feb 1;2018(2):CD001269. doi: 10.1002/14651858.CD001269.pub6

Comparison 7. Serious adverse events: Guillain‐Barré syndrome ‐ cohort studies.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Seasonal influenza vaccination and Guillain‐Barré syndrome 3   Risk Ratio (Random, 95% CI) 1.28 [0.85, 1.93]
1.1 General population (adjusted data) 2   Risk Ratio (Random, 95% CI) 1.29 [0.83, 2.02]
1.2 Pregnant women (unadjusted data) 1   Risk Ratio (Random, 95% CI) 0.65 [0.03, 15.95]